Bemrist Breezhaler 150/320 is a combination medication that contains two active ingredients: Mometasone Furoate and Indacaterol. It is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. COPD is a chronic lung disease characterized by airflow obstruction, which can cause symptoms such as shortness of breath, coughing, and wheezing.
Mometasone Furoate is a corticosteroid that helps reduce inflammation in the airways, while Indacaterol is a long-acting beta-agonist that helps relax and widen the air passages, making it easier to breathe.
Usage Information: Bemrist Breezhaler is typically inhaled orally using the Breezhaler device that comes with the medication. The recommended dosage may vary depending on the severity of your condition and individual response, so it’s crucial to follow your healthcare provider’s instructions.
Before using the medication, it’s essential to read the patient information leaflet that accompanies the product or consult your healthcare provider for proper inhalation technique. It’s usually recommended to inhale one capsule once daily, at the same time each day, to maintain consistent treatment.
Side Effects: Like any medication, Bemrist Breezhaler 150/320 can cause side effects. The most common side effects may include:
- Cough
- Headache
- Nasopharyngitis (inflammation of the nasal passages and pharynx)
- Upper respiratory tract infection
- Oral candidiasis (a fungal infection of the mouth)
These side effects are usually mild and temporary. However, if they persist or worsen, it’s important to inform your healthcare provider.
In some cases, Bemrist Breezhaler may cause more severe side effects, such as:
- Increased heart rate
- Chest pain
- Tremors or shakiness
- Irregular heartbeat
- Allergic reactions (rash, itching, swelling)
If you experience any severe or concerning side effects, it’s crucial to seek medical attention immediately.